Perturbations in skeletal muscle metabolism have been reported for a variety of neuromuscular diseases. However, the role of metabolism after constriction injury to a nerve and the associated muscle atrophy is unclear. We have analyzed rat tibialis anterior (TA) four weeks after unilateral constriction injury to the sciatic nerve (DMG) and in the contralateral control leg (CTRL) (n = 7) to investigate changes of the metabolome, immunohistochemistry and protein levels. Untargeted metabolomics identified 79 polar metabolites, 27 of which were significantly altered in DMG compared to CTRL. Glucose concentrations were increased 2.6-fold in DMG, while glucose 6-phosphate (G6-P) was unchanged. Intermediates of the polyol pathway were increased in DMG, particularly fructose (1.7fold). GLUT4 localization was scattered as opposed to clearly at the sarcolemma. Despite the altered localization, we found GLUT4 protein levels to be increased 7.8-fold while GLUT1 was decreased 1.7fold in nerve damaged TA. PFK1 and GS levels were both decreased 2.1-fold, indicating an inability of glycolysis and glycogen synthesis to process glucose at sufficient rates. In conclusion, chronic nerve constriction causes increased GLUT4 levels in conjunction with decreased glycolytic activity and glycogen storage in skeletal muscle, resulting in accumulation of intramuscular glucose and polyol pathway intermediates. Skeletal muscle atrophy is a pathological condition associated with many diseases. While protein metabolism is thought to be the main regulator of muscle size, many situations of atrophy and neuromuscular diseases are accompanied by changes to substrate metabolism as well. Critical illness myopathy (CIM) is a condition for which disturbances of glucose metabolism have been reported by our laboratory and others 1. Specifically, we have found the primary glucose transporter GLUT4 to be insufficiently translocated in CIM patients, resulting in decreased glucose supply and reduced AMPK activity 2. Besides CIM, a number of other neuromuscular disorders have been found to be show signs of changes to glucose metabolism in skeletal muscle such as amyotrophic lateral sclerosis (ALS), Charcot-Marie-Tooth neuropathy (CMT) or spinal muscular atrophy (SMA) 3-5. For example, it has been found that concentrations of glucose as well as fructose are increased in skeletal muscle samples of ALS patients, often accompanied by an early onset of insulin resistance 6. Early research in respect to nerve damage and glucose metabolism has reported that denervation is followed by insulin resistance, reduced glucose transport into the muscle, less glucose abundance and transiently decreased GLUT4 levels 7-9. A more recent study in mice found that despite decreased GLUT4 mRNA abundance, long term denervation was associated with increased GLUT4 protein levels potentially regulated by increased Akt activity 10. The same study found that glucose uptake in